Intracerebral haemorrhage and hepatitis C treatment

S Ferencz1, R Batey

  • 1Department of Gastroenterology, Division of Medicine, John Hunter Hospital, Newcastle, NSW, Australia.

Journal of Viral Hepatitis
|September 13, 2003
PubMed

Insights

Hepatitis C (HCV) patients experienced intracerebral haemorrhage. This study suggests a potential link between HCV infection, its treatment, and this severe neurological complication.

Area of Science:

  • Hepatology
  • Neurology
  • Clinical Medicine

Background:

  • Hepatitis C virus (HCV) infection affects millions globally.
  • Intracerebral haemorrhage (ICH) is a severe neurological event with significant morbidity and mortality.
  • Understanding risk factors for ICH in specific patient populations is crucial for preventative strategies.

Observation:

  • A cohort of 1460 patients with confirmed hepatitis C infection was monitored.
  • Three cases of intracerebral haemorrhage were identified within this cohort.
  • The occurrence of ICH in this population warrants further investigation.

Findings:

  • A potential association between hepatitis C virus infection and intracerebral haemorrhage is suggested.
  • The role of HCV treatments in the development of ICH is also considered.
  • The incidence rate of ICH in HCV-infected patients requires further epidemiological study.

Implications:

  • These findings highlight a potential neurological risk associated with hepatitis C.
  • Further research is needed to elucidate the mechanisms linking HCV, its treatments, and ICH.
  • Clinical vigilance for neurological complications in hepatitis C patients may be warranted.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...